Phase II Trial to Evaluate Laparoscopic Surgery for Stage 0/I Rectal Carcinoma

Overview

The purpose of this study is to examine the technical and oncological feasibility of laparoscopic surgery for rectal carcinoma

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2015

Detailed Description

Recently reported randomized controlled trials demonstrated that laparoscopic surgery was comparable or superior to open surgery regarding the long-term outcome for colon and rectosigmoidal carcinoma; however, controversy persists regarding the appropriateness of laparoscopic surgery for patients with rectal carcinoma because of the uncertainty of the long-term outcome, and of concerns over the safety of the procedure. In Japan, lateral lymph node dissection combined with total mesorectal excision remains the standard surgical procedure for patients with advanced lower rectal carcinoma, and lateral lymph node dissection by laparoscopy is still an unexplored frontier. To examine the technical and oncological feasibility of laparoscopic surgery for rectal carcinoma, a phase II trial will be conducted in patients with a preoperative diagnosis of stage 0/I rectal carcinoma, under the direction of the Japan Society of Laparoscopic Colorectal Surgery, to which leading hospitals in laparoscopic surgery for colorectal carcinoma in Japan are members.

Interventions

  • Procedure: laparoscopic surgery for rectal carcinoma
    • Laparoscopic resection of the rectum with adequate lymphadenectomy is performed according to the General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus edited by the Japanese Society for Cancer of the Colon and Rectum. The extent of lymphadenectomy and site of ligation and division of the inferior mesenteric vessels were decided by the surgeon in charge. Pneumoperitoneal approaches are used to explore the abdomen, mobilize the left side colon, identify critical structures and ligate the vascular pedicle. Mobilization of the rectum, excision of the mesorectum, rectal transection, removal of the specimen, and reconstruction are performed by the pneumoperitoneal approach or the extracorporeal approach via a small incision (<8 cm).

Arms, Groups and Cohorts

  • Experimental: Lap, 1
    • Patients undergoing laparoscopic surgery for rectal carcinoma

Clinical Trial Outcome Measures

Primary Measures

  • overall survival
    • Time Frame: 5 year

Secondary Measures

  • anastomotic leakage rate
    • Time Frame: 1 month

Participating in This Clinical Trial

Inclusion Criteria

1. Histologically proven rectal carcinoma. 2. Tumor located in the rectum. 3. Clinical Tis, T1, T2 N0 M0 4. Without multiple lesions other than carcinoma in situ 5. Tumor size <8 cm. 6. Sufficient organ function. 7. No bowel obstruction. 8. No history of major colorectal surgery. 9. No history of chemotherapy or radiotherapy. 10. Provide written informed consent. Exclusion Criteria:

1. Synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ. 2. Pregnant or lactating women. 3. Severe mental disease. 4. Severe pulmonary emphysema, interstitial pneumonitis or ischemic heart disease. 5. Continuous systemic steroid therapy.

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Japan Society of Laparoscopic Colorectal Surgery
  • Provider of Information About this Clinical Study
    • Masahiko Watanabe, Kitasato University Hospital
  • Overall Official(s)
    • Masahiko Watanabe, PhD, Study Chair, Kitasato University Hospital

References

Yamamoto S, Yoshimura K, Konishi F, Watanabe M. Phase II trial to evaluate laparoscopic surgery for Stage 0/I rectal carcinoma. Jpn J Clin Oncol. 2008 Jul;38(7):497-500. doi: 10.1093/jjco/hyn054. Epub 2008 Jun 26.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.